"It's not uncommon that a defamation suit is brought, not necessarily because the plaintiff expects to take it to trial, but instead, because they want to make a public announcement that what was said ...
Express Scripts and the PBM lobby are following in CVS Caremark’s footsteps in filing complaints challenging the FAIR Rx Act, which was passed earlier this year despite vehement opposition from PBMs.
April 30 (Reuters) - The federal judge overseeing nationwide litigation over the opioid crisis has denied pharmacy benefit managers OptumRx and Express Scripts’ demand that he recuse himself from ...
Many patients are losing access to the local pharmacies they know and trust because of pharmacy network decisions tied to health plans and pharmacy benefit managers, or PBMs, said ...
Express Scripts, the pharmacy benefits services business of The Cigna Group’s Evernorth, is making it easier for people to access a broader range of care services at independent pharmacies A new ...
Express Scripts, the pharmacy benefits services business of The Cigna Group's Evernorth, has entered into a collaboration with CPESN USA, a network of pharmacy providers that delivers health services, ...
Express Scripts said it will continue to evaluate biosimilars for Humira as they are approved and expects adding these products to its formulary will pay off in significant savings. (Express Scripts) ...
Express Scripts, one of the largest pharmacy benefit managers in the country, overcharged U.S. Postal Service employees by a whopping $45 million for their prescription drugs during a recent five-year ...
Express Scripts — one of the largest pharmacy benefit managers in the country — has notched a major partnership with independent pharmacies, amid contentious relations between the two industries. The ...
Express Scripts members will now have access to Propeller’s FDA-cleared digital platform for respiratory health. Today, the two companies announced a partnership which they claim is the largest ...
Express Scripts, the pharmacy benefits management business of the Cigna Group's Evernorth, will add three additional biosimilars to its National Preferred Formulary that it said will compete with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results